Paige Watson, in Lincoln, NE - Counselor

Paige Watson, is a Counselor - Mental Health based in Lincoln, Nebraska. Paige Watson is licensed to practice in Nebraska (license number 13509) and her current practice location is 620 N 48th St Ste 303, Lincoln, Nebraska. She can be reached at her office (for appointments etc.) via phone at (918) 859-2326.

NPI number for Paige Watson is 1043093529 and her current mailing address is 620 N 48th St Ste 303, Lincoln, Nebraska. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1043093529.

Contact Information

	Paige Watson,
	620 N 48th St Ste 303, Lincoln, NE 68504-3467
	(918) 859-2326
	Not Available

Healthcare Provider's Profile

Full Name	Paige Watson
Gender	Female
Speciality	Counselor - Mental Health
Location	620 N 48th St Ste 303, Lincoln, Nebraska
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1043093529
Provider Enumeration Date: 08/17/2023
Last Update Date: 08/17/2023

Medical Identifiers

Medical identifiers for Paige Watson such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1043093529	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
1041C0700X	Social Worker - Clinical	7884 (Nebraska)	Secondary
101YM0800X	Counselor - Mental Health	13509 (Nebraska)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Paige Watson is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Paige Watson, 620 N 48th St Ste 303, Lincoln, NE 68504-3467 Ph: () -	Paige Watson, 620 N 48th St Ste 303, Lincoln, NE 68504-3467 Ph: (918) 859-2326

News Archive

Shire's Replagal and VPRIV data on Gaucher and Fabry patients presented at ACMG meeting

Shire plc, the global specialty biopharmaceutical company, presented new data for Replagal in patients with Fabry disease, and VPRIV in patients with type 1 Gaucher disease, at the 2011 American College of Medical Genetics' Annual Clinical Genetics Meeting, held in Vancouver, BC, from March 16-20, 2011.

NIH to award $64M under Transformative Research Projects program

The National Institutes of Health will award up to $64 million over five years to encourage exploration of exceptionally innovative and original research ideas that have the potential for extraordinary impact.

Alcoholism in Hispanics dependent on gene/environment interaction

Hispanics with alcohol-induced problems - especially male Mexican Americans - have significantly worse health and welfare than those with other ethnic backgrounds. This study examined the influence of gene/environment interaction on alcoholism among Mexican Americans. Researchers have found that interaction between education and a polymorphism of the reward gene contribute to severe alcoholism among Mexican Americans.

OPHN1 protein mediates mGluR-dependent longterm depression at synapses

Scientists at Cold Spring Harbor Laboratory (CSHL) have solved part of a puzzle concerning the relationship between changes in the strength of synapses - the tiny gaps across which nerve cells in the brain communicate - and dysfunctions in neural circuits that have been linked with drug addiction, mental retardation and other cognitive disorders.

Paige Watson, - in Lincoln, NE